Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY.
Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY.
JCO Oncol Pract. 2022 Jun;18(6):e1023-e1033. doi: 10.1200/OP.21.00684. Epub 2022 Feb 8.
Black and Hispanic individuals with diabetes receive less recommended diabetes care after cancer diagnosis than non-Hispanic Whites (NHW). We sought to determine whether racial/ethnic minorities with diabetes and cancer were at increased risk of diabetes-related emergency department (ED) visits and hospitalizations compared with NHW.
Using SEER cancer registry data linked to Medicare claims from 2006 to 2014, we included Medicare beneficiaries age 66+ years diagnosed with incident nonmetastatic breast, prostate, or colorectal cancer between 2007 and 2012 who had diabetes. Our primary outcome was any diabetes-related ED visit or hospitalization 366-731 days after cancer diagnosis. Using Fine-Gray subdistribution hazard models, we examined whether risk of ED visits or hospitalizations was higher for racial/ethnic minorities compared with NHW.
We included 40,059 beneficiaries with mean age 75.5 years (standard deviation 6.3), 45.6% were women, and 28.9% were non-White. Overall, 825 (2.1%) had an ED visit and 3,324 (8.3%) had a hospitalization related to diabetes in the 366-731 days after cancer diagnosis. Compared with NHW, Black individuals were more likely to have ED visits (2.9% 2.0%; < .0001) and hospitalizations (11.7% 7.8%; < .0001). Adjusting for potential confounders, Black (adjusted hazard ratio, 1.22; 95% CI, 1.12 to 1.35) individuals had a higher risk of any ED visit or hospitalization compared with NHW.
Black individuals with diabetes and cancer were at increased risk for diabetes-related ED visits and hospitalizations in the second year after cancer diagnosis compared with NHW even after accounting for confounders.
与非西班牙裔白人(NHW)相比,患有糖尿病的黑人和西班牙裔个体在癌症诊断后接受的推荐糖尿病护理较少。我们旨在确定患有糖尿病和癌症的少数族裔与 NHW 相比,是否有更高的风险出现与糖尿病相关的急诊就诊和住院治疗。
我们使用 SEER 癌症登记数据,将其与 2006 年至 2014 年的医疗保险索赔相链接,纳入了年龄在 66 岁及以上、2007 年至 2012 年间诊断出患有非转移性乳腺癌、前列腺癌或结直肠癌且患有糖尿病的医疗保险受益人。我们的主要结局是癌症诊断后 366-731 天内任何与糖尿病相关的急诊就诊或住院治疗。使用 Fine-Gray 亚分布风险模型,我们研究了与 NHW 相比,少数族裔的急诊就诊或住院治疗风险是否更高。
我们纳入了 40059 名平均年龄为 75.5 岁(标准差为 6.3)的受益人,其中 45.6%为女性,28.9%为非白人。总体而言,在癌症诊断后 366-731 天内,有 825 人(2.1%)有急诊就诊,3324 人(8.3%)有与糖尿病相关的住院治疗。与 NHW 相比,黑人更有可能出现急诊就诊(2.9% 2.0%; <.0001)和住院治疗(11.7% 7.8%; <.0001)。在调整潜在混杂因素后,与 NHW 相比,黑人(调整后的风险比,1.22;95%置信区间,1.12 至 1.35)出现任何急诊就诊或住院治疗的风险更高。
与 NHW 相比,患有糖尿病和癌症的黑人在癌症诊断后第二年出现与糖尿病相关的急诊就诊和住院治疗的风险更高,即使在考虑了混杂因素后也是如此。